News

Critical Metals is surging nearly 20% while its rare earth peers sit flat or slide lower, and no company announcement explains the gap. One unverified catalyst keeps surfacing in trader circles, and it has nothing to do with the ground under Greenland.

Antimony prices collapsed, but zeolite surged 110% and government contracts accelerate.

U.S. Antimony's 2026 sales outlook just took a big turn for the worse.

Moby summary of United States Antimony Corporation's Q2 2026 earnings call

Zeolite revenue doubles and liquidity strengthens to $62.2 million, yet lower antimony prices compress margins and prompt a reduced full-year outlook.

United States Antimony (NYSE:UAMY) reported lower second-quarter revenue as antimony selling prices declined sharply from a year earlier, while the company expanded volumes, built inventory for government deliveries and advanced mining and processing projects in North America. Revenue for the quart

United States Antimony (NYSE:UAMY) reported nearly flat first-quarter sales but a wider loss as management said the company is absorbing higher costs tied to an expected production ramp-up and a broader push into critical minerals beyond antimony. Senior Vice President and Chief Financial Officer R

Moby summary of United States Antimony Corporation's Q1 2026 earnings call

Despite a net loss, UAMY's diversified mineral portfolio and substantial government grants position the company for future growth.

Moby summary of United States Antimony Corporation's Q3 2026 earnings call

United States Antimony Corp (UAMY) reports a 163% revenue increase and a major tungsten acquisition, while facing delays in facility expansion and reliance on foreign antimony sources.